Clinical trial
Development of a Non-Invasive Prognostic Test for Graves Orbitopathy
NCT07472062 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a Non-Invasive Prognostic Test for Graves Orbitopathy
- Lead sponsor
- University Hospital, Ghent
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 13, 2023
- Completion date
- December 31, 2026
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
graves orbitopathy, hyperthyroidism